Click on a filter below to refine your search. Remove a filter to broaden your search.
The year-over-year age difference was an independent predictor for adjuvant radiation and endocrine therapy recommendations at age 70 versus 69 years.
Of the reduction, 29% was due to treatment of metastatic breast cancer and 25% was due to mammography screening.
Older age, white race, and higher education were patient factors associated with initial active surveillance uptake in an unadjusted analysis.
At 30 days after discharge, the mortality rate was 3.2% and skilled nursing facility use rate was 2.6%.
The meta-analysis only shows a 110-day survival benefit for colorectal cancer screening with sigmoidoscopy.
But an increase in cardiovascular disease mortality was seen after more than 20 years of follow-up among older women.
A reduction was seen in the rate of one or more opioid days and in the rate of one or more pain-related hospital events.
Racial and ethnic disparities, however, persisted for various cancers, including prostate, male lung and bronchus, and female colorectal cancer.
The leading contributors to the widening gender life expectancy gap from 2019 to 2021 included COVID-19 and unintentional injuries.
An increased risk was seen for atrial fibrillation and cerebrovascular disease, among others.